Literature DB >> 34433080

Two cases of T cell lymphoma following Piggybac-mediated CAR T cell therapy.

Axel Schambach1, Michael Morgan2, Boris Fehse3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34433080      PMCID： PMC8417502          DOI： 10.1016/j.ymthe.2021.08.013

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   12.910


× No keyword cloud information.
  9 in total

1.  T-cell receptor diversity prevents T-cell lymphoma development.

Authors:  S Newrzela; N Al-Ghaili; T Heinrich; M Petkova; S Hartmann; B Rengstl; A Kumar; H-M Jäck; S Gerdes; I Roeder; M-L Hansmann; D von Laer
Journal:  Leukemia       Date:  2012-05-30       Impact factor: 11.528

2.  Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.

Authors:  Joseph A Fraietta; Christopher L Nobles; Morgan A Sammons; Stefan Lundh; Shannon A Carty; Tyler J Reich; Alexandria P Cogdill; Jennifer J D Morrissette; Jamie E DeNizio; Shantan Reddy; Young Hwang; Mercy Gohil; Irina Kulikovskaya; Farzana Nazimuddin; Minnal Gupta; Fang Chen; John K Everett; Katherine A Alexander; Enrique Lin-Shiao; Marvin H Gee; Xiaojun Liu; Regina M Young; David Ambrose; Yan Wang; Jun Xu; Martha S Jordan; Katherine T Marcucci; Bruce L Levine; K Christopher Garcia; Yangbing Zhao; Michael Kalos; David L Porter; Rahul M Kohli; Simon F Lacey; Shelley L Berger; Frederic D Bushman; Carl H June; J Joseph Melenhorst
Journal:  Nature       Date:  2018-05-30       Impact factor: 49.962

3.  Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy.

Authors:  Nirali N Shah; Haiying Qin; Bonnie Yates; Ling Su; Haneen Shalabi; Mark Raffeld; Mark A Ahlman; Maryalice Stetler-Stevenson; Constance Yuan; Shuang Guo; Siyuan Liu; Stephen H Hughes; Terry J Fry; Xiaolin Wu
Journal:  Blood Adv       Date:  2019-08-13

4.  Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.

Authors:  Tim Heinrich; Benjamin Rengstl; Alexander Muik; Mina Petkova; Frederike Schmid; Robin Wistinghausen; Kathrin Warner; Giuliano Crispatzu; Martin-Leo Hansmann; Marco Herling; Dorothee von Laer; Sebastian Newrzela
Journal:  Mol Ther       Date:  2013-04-23       Impact factor: 11.454

5.  Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.

Authors:  David C Bishop; Leighton E Clancy; Renee Simms; Jane Burgess; Geetha Mathew; Leili Moezzi; Janine A Street; Gaurav Sutrave; Elissa Atkins; Helen M McGuire; Brian S Gloss; Koon Lee; Wei Jiang; Karen Maddock; Georgia McCaughan; Selmir Avdic; Vicki Antonenas; Tracey A O'Brien; Peter J Shaw; David O Irving; David J Gottlieb; Emily Blyth; Kenneth P Micklethwaite
Journal:  Blood       Date:  2021-10-21       Impact factor: 22.113

6.  Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery.

Authors:  Melanie Galla; Axel Schambach; Christine S Falk; Tobias Maetzig; Johannes Kuehle; Kathrin Lange; Daniela Zychlinski; Niels Heinz; Martijn H Brugman; Gudrun Göhring; Zsuzsanna Izsvák; Zoltán Ivics; Christopher Baum
Journal:  Nucleic Acids Res       Date:  2011-05-23       Impact factor: 16.971

7.  Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cells.

Authors:  Kenneth P Micklethwaite; Kavitha Gowrishankar; Brian S Gloss; Ziduo Li; Janine A Street; Leili Moezzi; Melanie A Mach; Gaurav Sutrave; Leighton E Clancy; David C Bishop; Raymond H Y Louie; Curtis Cai; Jonathan Foox; Matthew MacKay; Fritz J Sedlazeck; Piers Blombery; Christopher E Mason; Fabio Luciani; David J Gottlieb; Emily Blyth
Journal:  Blood       Date:  2021-10-21       Impact factor: 25.476

8.  Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4(+) T Cells.

Authors:  Andreas Gogol-Döring; Ismahen Ammar; Saumyashree Gupta; Mario Bunse; Csaba Miskey; Wei Chen; Wolfgang Uckert; Thomas F Schulz; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Mol Ther       Date:  2016-01-12       Impact factor: 11.454

9.  HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells.

Authors:  Daniela Cesana; Francesca R Santoni de Sio; Laura Rudilosso; Pierangela Gallina; Andrea Calabria; Stefano Beretta; Ivan Merelli; Elena Bruzzesi; Laura Passerini; Silvia Nozza; Elisa Vicenzi; Guido Poli; Silvia Gregori; Giuseppe Tambussi; Eugenio Montini
Journal:  Nat Commun       Date:  2017-09-08       Impact factor: 14.919
  9 in total
  3 in total

Review 1.  Gene editing to enhance the efficacy of cancer cell therapies.

Authors:  Tara Murty; Crystal L Mackall
Journal:  Mol Ther       Date:  2021-10-18       Impact factor: 11.454

2.  Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy.

Authors:  Jaitip Tipanee; Ermira Samara-Kuko; Thierry Gevaert; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2022-06-16       Impact factor: 12.910

Review 3.  Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms.

Authors:  Alexander Michels; Naphang Ho; Christian J Buchholz
Journal:  Mol Ther       Date:  2022-05-20       Impact factor: 12.910
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.